ABAXIS INC
10-K/A, 1999-11-30
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: SPATIALIGHT INC, SC 13D, 1999-11-30
Next: MERRILL LYNCH MINNESOTA MUN BOND FD OF MERRILL LYNCH MULTI S, 485BPOS, 1999-11-30



<PAGE>   1

                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                   FORM 10-K/A

                               Amendment No. 1 to

              Annual report pursuant to Section 13 or 15(d) of the
    Securities Exchange Act of 1934 for the fiscal year ended MARCH 31, 1999

                        Commission File Number: 000-19720

                                  ABAXIS, INC.
             (Exact name of registrant as specified in its charter)

                 CALIFORNIA                               77-0213001
       (State or other jurisdiction of                 (I.R.S. Employer
       incorporation or organization)                 Identification No.)

                             1320 Chesapeake Terrace
                               Sunnyvale, CA 94089
               (Address of principal executive offices) (Zip code)

Registrant's telephone number, including area code: 408.734.0200
Securities registered pursuant to Section 12(b) of the Act: None
Securities registered pursuant to Section 12(g) of the Act: Common Stock, no par
value

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required
to file such reports), and (2) has been subject to such filing requirements for
the past 90 days.  YES [X]  NO [ ]

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405
of Regulation S-K is not contained herein, and will not be contained, to the
best of registrant's knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-K or any amendment to this
Form 10-K. [ ]

The aggregate market value of registrant's voting stock held by non-affiliates
of registrant, based upon the closing sale price of the Common Stock on October
8, 1999, as reported on the Nasdaq National Market, was approximately
$68,574,363. Shares of Common Stock held by each officer, director and holder of
5% or more of the outstanding Common Stock have been excluded in that such
persons may be deemed to be affiliates. This determination of affiliate status
is not necessarily a conclusive determination for other purposes.

Outstanding shares of registrant's Common Stock, no par value, as of October 8,
1999: 13,975,643.

This Amendment contains 6 pages.


<PAGE>   2

                                   FORM 10-K/A
                                 AMENDMENT NO. 1

        The undersigned registrant hereby amends the following items of its
Annual Report on Form 10-K for the fiscal year ended March 31, 1999, as set
forth in the pages attached hereto:


                                    PART III

ITEM 11.       EXECUTIVE COMPENSATION.


                    EXECUTIVE COMPENSATION AND OTHER MATTERS

        The following table sets forth information concerning the compensation
during the fiscal years ended March 31, 1999, March 31, 1998 and March 31, 1997
of the Chief Executive Officer of the Company during fiscal 1999 and the four
other most highly compensated executive officers of the Company whose total
salary and bonus for fiscal 1999 exceeded $100,000, for services in all
capacities to the Company, during fiscal 1999.

                                  SUMMARY COMPENSATION TABLE

<TABLE>
<CAPTION>
                                                                                LONG-TERM
                                       FISCAL                                 COMPENSATION
NAME AND PRINCIPAL POSITION             YEAR         ANNUAL COMPENSATION($)      AWARDS
- ---------------------------             ----         ----------------------   ------------
                                                                                OPTIONS
                                                      SALARY         BONUS      (SHARES)
                                        ----         --------       -------   ------------
<S>                                     <C>          <C>            <C>          <C>
Clinton H. Severson..............       1999         $200,000       $60,450      200,000
  Chairman of the Board of              1998          193,254        73,950       50,000
  Directors, President and Chief        1997          146,535            -0-     250,000
  Executive Officer

Robert Milder....................       1999          $93,000       $20,400       65,000
  Vice President of Operations          1998              -0-           -0-          -0-
                                        1997              -0-           -0-          -0-

Vladimir E. Ostoich..............       1999         $144,740       $47,630       25,000
  Vice President of Marketing and       1998          139,173        60,550          -0-
  Sales for North America               1997          145,287        21,700       25,000

Diane Oates......................       1999          $90,000       $48,605       10,000
  Vice President of                     1998           81,975        18,785       30,000
  Regulatory/Quality Systems            1997              -0-           -0-          -0-

Daniel Wong......................       1999         $135,000       $47,630          -0-
  Vice President of Development         1998          129,808        60,505          -0-
                                        1997          135,296        22,825       25,000
</TABLE>



                                       2.
<PAGE>   3

STOCK OPTIONS GRANTED IN FISCAL 1999

        The following table provides the specified information concerning grants
of options to purchase Common Stock made during the fiscal year ended March 31,
1999 to the persons named in the Summary Compensation Table.

                                 OPTION GRANTS IN FISCAL 1999

<TABLE>
<CAPTION>
                                             INDIVIDUAL GRANTS
                              ----------------------------------------------
                                            PERCENT OF
                                              TOTAL
                                             OPTIONS                            POTENTIAL REALIZABLE
                                            GRANTED TO                             VALUE AT ASSUMED
                              OPTIONS       EMPLOYEES  EXERCISE                 ANNUAL RATES OF STOCK
                              GRANTED       IN FISCAL    PRICE    EXPIRATION    PRICE APPRECIATION FOR
NAME                           (#)(1)         YEAR     ($/SH)(2)     DATE           OPTION TERM(3)
- ----------------------------  -------         -----    ---------  ----------    ----------------------
                                                                                    5%($)     10%($)
                                                                                  --------   --------
<S>                           <C>             <C>         <C>      <C>            <C>        <C>
Clinton Severson............. 200,000         26.1%       $1.56    01/26/09       $196,530   $498,045
Robert Milder................  65,000          8.5%       $2.16    10/26/08        $88,445   $224,136
Diane Oates..................  10,000          1.3%       $2.56     5/26/08        $16,119    $40,848
Vladimir E. Ostoich..........  25,000          3.3%       $1.88    10/26/08        $29,479    $74,707
</TABLE>

- ------------

(1) All options granted in fiscal 1999 were granted pursuant to the Company's
    1998 Stock Option Plan (the "1998 Plan"). These options vest and become
    exercisable at the rate of one-fourth on the first anniversary of the date
    of grant and 1/48 per month thereafter for each full month of the optionee's
    continuous employment by the Company. Under the 1998 Plan, the Board retains
    discretion to modify the terms, including the price, of outstanding options.
    For additional information regarding options, see "Change of Control
    Arrangements."

(2) All options in this table have exercise prices equal to the fair market
    value on the date of grant.

(3) Potential gains are net of exercise price, but before taxes associated with
    exercise. These amounts represent certain assumed rates of appreciation
    only, based on the Securities and Exchange Commission rules. Actual gains,
    if any, on stock option exercises are dependent on the future performance of
    the Common Stock, overall market conditions and the option holder's
    continued employment through the vesting period. The amounts reflected in
    this table may not necessarily be achieved.



                                       3.
<PAGE>   4

OPTION EXERCISES AND FISCAL 1999 YEAR-END VALUES

        The following table provides the specified information concerning
exercises of options to purchase Common Stock in the fiscal year ended March 31,
1999, and unexercised options held as of March 31, 1999, by the persons named in
the Summary Compensation Table.

                OPTION EXERCISES AND FISCAL 1999 YEAR-END VALUES

<TABLE>
<CAPTION>
                                                NUMBER OF UNEXERCISED
                       SHARES                           OPTIONS            VALUE OF UNEXERCISED IN-THE-
                       ACQUIRED     VALUE             AT 3/31/99          MONEY OPTIONS AT 3/31/99($)(2)
                          ON      REALIZED   ---------------------------- ------------------------------
SHARES                 EXERCISE      ($)     EXERCISABLE(1) UNEXERCISABLE EXERCISABLE(1)  UNEXERCISABLE
- ---------------------- --------   --------   -------------- ------------- -------------- ---------------
<S>                    <C>        <C>        <C>            <C>           <C>            <C>
Clinton H. Severson....   -0-        -0-       215,626         284,375       $    --        $75,000
Robert Milder..........   -0-        -0-            --          65,000            --        $ 1,563
Vladimir E. Ostoich....   -0-        -0-        96,563          34,062       $22,125        $ 1,563
Diane Oates............   -0-        -0-        12,500          27,500            --             --
Daniel Wong............   -0-        -0-        75,743           9,257            --             --
</TABLE>

- ------------

(1) Company stock options generally vest one-fourth on the first anniversary of
    the date of grant and 1/48 per month thereafter for each full month of the
    optionee's continuous employment by the Company. All options are exercisable
    only to the extent vested.

(2) The value of the unexercised in-the-money options is based on the closing
    price of the Common Stock ($1.94 per share as reported on the Nasdaq
    National Market on March 31, 1999) and is net of the exercise price of such
    options.

COMPENSATION OF DIRECTORS

All non-employee directors of the Company receive compensation in the amount of
$750 per Board meeting they attend plus reimbursement of reasonable travel
expenses incurred. In addition, Dr. Tucker serves as a consultant to the Company
and receives monthly compensation of $1,000 plus reimbursement of expenses for
attending meetings at or on behalf of the Company. Each of the Company's
non-employee directors also receives an automatic annual grant of options to
purchase 4,000 shares of Common Stock under the Company's 1992 Outside Directors
Stock Option Plan. In addition, Dr. Tucker receives an additional annual grant
of options to purchase 5,000 shares for serving as a consultant. Clinton H.
Severson is a director of the Company and also an employee of the Company. He
does not receive any compensation for his services as a member of the Board of
Directors.

CHANGE OF CONTROL ARRANGEMENTS

The Company's 1998 Stock Option Plan and the 1992 Outside Directors Stock Option
Plan (the "Option Plans") provide that, in the event of a transfer of control of
the Company ("Transfer of Control"), the surviving, continuing, successor or
purchasing corporation or a parent corporation thereof, as the case may be (the
"Acquiring Corporation"), shall either assume the Company's rights and
obligations under stock option agreements outstanding under the Option Plans
(the "Options") or substitute options for the Acquiring Corporation's stock for
such outstanding Options. In the event the Acquiring Corporation elects not to
assume or substitute for such outstanding Options in connection with a merger
constituting a



                                       4.
<PAGE>   5

Transfer of Control, the Company's Board shall provide that any unexercisable
and/or unvested portion of the outstanding Options shall be immediately
exercisable and vested as of a date prior to the Transfer of Control, as the
Company's Board so determines. Any Options which are neither assumed by the
Acquiring Corporation, nor exercised as of the date of the Transfer of Control,
shall terminate effective as of the date of the Transfer of Control. Options
which are assumed by the Acquiring Corporation shall become exercisable and
vested as provided under the relevant stock option agreements under the Option
Plans, unless the Acquiring Corporation terminates the option holder under
certain circumstances defined in the Option Plans. Under such circumstances, the
holder's options shall become immediately exercisable and vested as of the date
of termination.

SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE

Section 16(a) of the Securities Exchange Act of 1934 requires the Company's
executive officers, directors and persons who beneficially own more than 10% of
the Company's Common Stock to file initial reports of ownership and reports of
changes in ownership with the Securities and Exchange Commission ("SEC"). Such
persons are required by SEC regulations to furnish the Company with copies of
all Section 16(a) forms filed by such persons.

EMPLOYMENT AGREEMENTS

In March 1997, the Company entered into an employment agreement with Clinton H.
Severson, providing Mr. Severson as President and Chief Executive Officer of
Abaxis with six months of salary and benefits if his employment with the Company
is terminated for other than cause.



                                       5.
<PAGE>   6

                                   FORM 10-K/A

                                 AMENDMENT NO. 1


        Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this amendment to be signed on its behalf by the
undersigned, thereunto duly authorized.



                                        ABAXIS, INC.



                                        By:  /s/ Clinton H. Severson
                                            ------------------------------------
                                             Clinton H. Severson
                                             Chairman of the Board, President
                                             and Chief Executive Officer


Date:  November 29, 1999



                                       6.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission